[{"from": "human", "value": "Could you give me a brief overview of this molecule? [C][C][=Branch1][C][=O][N][C][=C][Branch2][Ring2][Ring2][C][=C][C][=Branch1][Ring2][=C][Ring1][=Branch1][N][C][=N][C][=C][Branch2][Ring1][C][C][=N][N][Ring1][Branch1][C][=Branch1][Ring2][=C][Ring1][=Branch2][N][C][C][C][Ring1][Ring1][C][#N][N][Branch1][C][C][C][C][N]"}, {"from": "gpt", "value": "The molecule is a pyrazolopyrimidine that is pyrazolo[1,5-a]pyrimidine which is substituted at positions 3, 5, and 7 by cyano, {3-acetamido-4-[(2-aminoethyl)(methyl)amino]phenyl}nitrilo and cyclopropylnitrilo groups, respectively. It is a DYRK2 and CSNK2A2 kinase inhibitor. It has a role as an EC 2.7.12.* [dual-specificity kinases (those acting on Ser/Thr and Tyr residues)] inhibitor, an antineoplastic agent and an EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor. It is a pyrazolopyrimidine, a member of cyclopropanes, a nitrile, a substituted aniline, a secondary amino compound, a member of acetamides and a tertiary amino compound."}]